Abbott Laboratories (SWX:ABT)
Switzerland · Delayed Price · Currency is CHF | Market Cap | 185.88B |
| Revenue (ttm) | 34.28B |
| Net Income (ttm) | 11.08B |
| Shares Out | n/a |
| EPS (ttm) | 6.34 |
| PE Ratio | 16.78 |
| Forward PE | 24.60 |
| Dividend | 1.96 (1.93%) |
| Ex-Dividend Date | Jul 15, 2025 |
| Volume | 35 |
| Average Volume | 2 |
| Open | 102.00 |
| Previous Close | 104.00 |
| Day's Range | 102.00 - 102.00 |
| 52-Week Range | 92.00 - 106.00 |
| Beta | 0.68 |
| RSI | 1.21 |
| Earnings Date | Oct 15, 2025 |
About Abbott Laboratories
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism,... [Read more]
Financial Performance
In 2024, Abbott Laboratories's revenue was $41.95 billion, an increase of 4.59% compared to the previous year's $40.11 billion. Earnings were $13.35 billion, an increase of 134.19%.
Financial numbers in USD Financial StatementsNews
Best Dividend Aristocrats For October 2025
Dividend Aristocrats, tracked by NOBL, outperformed SPY in August but lagged year-to-date, with notable dispersion among individual stock returns. Dividend growth remains robust, with 55 of 69 Aristoc...
Abbott Hosts Conference Call for Third-Quarter Earnings
ABBOTT PARK, Ill., Sept. 24, 2025 /PRNewswire/ -- Abbott (NYSE: ABT) will announce its third-quarter 2025 financial results on Wednesday, Oct. 15, before the market opens.
These Dividend Stocks Have Big Yields and Are Beating the Odds
Income is lagging growth this year. But companies like Seagate, Newmont, Tapestry and CVS offer the best of both worlds: solid dividend yields and strong stock performance.
Daily Dividend Report: Kroger, TXN, Philip Morris, Abbott, GE
The Kroger's Board of Directors today declared a quarterly dividend of 35 cents per share to be paid on December 1, 2025, to shareholders of record as of the close of business on November 14, 2025. Th...
1 Dividend King To Hold And 2 Worth Buying Now
It's often said that cash is king, but I would take it one step further. Abbott Laboratories is an AA-rated Dividend King with healthy growth prospects but a rich valuation. I'm waiting for a pullback...
Abbott Laboratories (ABT) Maintains Quarterly Dividend at $0.59
Abbott Laboratories (ABT) Maintains Quarterly Dividend at $0.59
Abbott Laboratories declares $0.59 dividend
Abbott Declares 407th Consecutive Quarterly Dividend
ABBOTT PARK, Ill., Sept. 19, 2025 /PRNewswire/ -- The board of directors of Abbott (NYSE: ABT) today declared a quarterly common dividend of 59 cents per share.
ABT Factor-Based Stock Analysis - Peter Lynch
Below is Validea's guru fundamental report for ABBOTT LABORATORIES (ABT). Of the 22 guru strategies we follow, ABT rates highest using our P/E/Growth Investor model based on the published strategy of ...
ABT January 2028 Options Begin Trading
Investors in Abbott Laboratories (Symbol: ABT) saw new options begin trading today, for the January 2028 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, i...
Peter Lynch Detailed Fundamental Analysis - ABT
Below is Validea's guru fundamental report for ABBOTT LABORATORIES (ABT). Of the 22 guru strategies we follow, ABT rates highest using our P/E/Growth Investor model based on the published strategy of ...
Texas Rep. Julie Johnson Sold Up to $885K Worth of 3M Stock
September 11, 2025 records indicate that Representative Julie Johnson filed a sale of 3M (NYSE: MMM), valued between $59,059 and $885,000. According to the September filing, the transaction occurred ...
Inside Abbott's big bet on the future of healthcare
Abbott CEO highlights the company's devices that could make healthcare faster and easier.
Abbott to take $200 million tariff hit: What it means for patients
Abbott's CEO explains what tariffs mean for the company and its patients. Transcript: CAROLINE WOODS: So while you're working on all of that, you're also having to plan for and account for tariffs tha...
Abbott's Navitor™ TAVI System Receives CE Mark for Expanded Indication to Treat More People With Aortic Stenosis
Navitor is now approved as a minimally invasive alternative to surgery for patients in Europe with symptomatic, severe aortic stenosis (a common and life-threatening heart valve disease) who are at lo...
Abbott CEO reveals the biggest disruptions in healthcare
An inside look into Abbott's momentum across diagnostics and devices, tariff impacts, and how AI will transform healthcare within five years. Transcript: CAROLINE WOODS: Joining me now, Robert Ford, C...
Best Dividend Aristocrats For September 2025
Dividend Aristocrats have shown mixed 2025 performance, with some delivering double-digit gains and others lagging, but overall stability remains a hallmark. Dividend growth is robust, with 53 of 69 A...
Best Dividend Kings: August 2025
Dividend Kings underperformed SPY year-to-date but are showing stronger gains in August, with several stocks achieving double-digit returns in 2025. Fifteen Dividend Kings currently appear undervalued...
Buy Well Health Technologies, Abbott Laboratories and Medtronic: Portfolio manager
Neela White, Portfolio Manager at Blue Wing Advisory Group, Raymond James, joins BNN Bloomberg to discuss an outlook on the market as well as healthcare stocks.
Abbott and Big Ten Conference Rally Students, Alumni, and Fans to Save Lives and Win $1 Million for Their School by Donating Blood This College Football Season
All 18 Big Ten universities will go head-to-head in Year 2 of the nationwide challenge, the 'We Give Blood' drive, to inspire the most blood donations from students, alumni, and fans with the winning ...
Chris Blumas' Past Picks: Brookfield Corp, Abbott Labs & Great-West Lifeco
Chris Blumas, Portfolio Manager at Raymond James Investment Counsel, discusses his past stock picks and how they're doing in the market today.
Recent Filing Shows That Rep. Josh Gottheimer Sold Over $6K Worth of Abbott Laboratories Stock
A August filing shows that Representative Josh Gottheimer reported a sale in Abbott Laboratories (NYSE: ABT), valued between $6,006 and $90,000. The transaction date is listed as July 18, 2025, with ...
Abbott India's profit climbs on healthy pharmaceutical demand
Drugmaker Abbott India reported an 11.5% rise in first-quarter profit on Tuesday, driven by healthy sales in its mainstay pharmaceuticals segment.
Abbott Laboratories (ABT) Faces Stock Dip Despite Positive YTD Performance
Abbott Laboratories (ABT) Faces Stock Dip Despite Positive YTD Performance